Natco Pharma is currently trading at Rs. 796.25, up by 2.60 points or 0.33% from its previous closing of Rs. 793.65 on the BSE.
The scrip opened at Rs. 788.00 and has touched a high and low of Rs. 799.75 and Rs. 784.45 respectively. So far 3879 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 830.00 on 27-Feb-2017 and a 52 week low of Rs. 390.00 on 29-Mar-2016.
Last one week high and low of the scrip stood at Rs. 811.00 and Rs. 784.45 respectively. The current market cap of the company is Rs. 13915.86 crore.
The promoters holding in the company stood at 51.24%, while Institutions and Non-Institutions held 26.02% and 22.74% respectively.
Natco Pharma and the University of Hyderabad (UoH) have signed a Memorandum of Understanding (MoU) to carry out advance research in the areas of pharmaceutical segment. The focus areas would be discovery of novel drugs, development of drug delivery systems viz., nano formulations of new chemical entities and biotechnological processes for specific products with potential commercial importance.
Both the entities will promote cooperation in academic exchange, R & D collaborations, training and research in the areas of biotechnology, pharmacology, toxicology, pharmaceutical technology and organising of national and international symposia, conferences, specialized exhibitions etc.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
